KV

Klaus Veitinger

Venture Partner at OrbiMed Advisors

New York City Metropolitan Area

Overview

Work Experience

O

OrbiMed

  • Venture Partner

    2007 - Current

SP

Sparrow Pharmaceuticals, Inc.

  • Chairman of the Board

    2021

AM

Alpheus Medical, Inc

  • Executive Chairman

    2020

NI

Neurogastrx, Inc.

  • Chairman of the Board

    2017

FDA - Brain Cancer Research Roundtable

  • Investor Representative

    2021

s

scPharmaceuticals

  • Board Member

    2017

CR

Cure Rare Disease

  • Board Member

    2024

TI

Tricida, Inc.

  • Chairman of the Board

    2013 - 2023

Education

Investments

Sparrow Pharmaceuticals

Series A

Total Funding: $60M

Alpheus Medical

Series A

Total Funding: $30M

Neurogastrx

Series A

Total Funding: $110M

Promentis Pharmaceuticals

Series C

Total Funding: $26M

Relevant Websites